[1]
ABOUHUSSEIN, D., TEAIMA, M.H., AL-NUSEIRAT, A., BADARY, O., EL-NABARAWI, M.A. and EL-MONEM, R.A. 2022. FORMULATION AND CHARACTERIZATION OF ODT USING DIFFERENT CO-PROCESS CONTAINING DACLATSVIR: IN VITRO AND IN VIVO PHARMACOKINETICS STUDY ON HEALTHY VOLUNTEERS FOR HEPATITIS C TREATMENT. International Journal of Applied Pharmaceutics. 14, 5 (Sep. 2022), 105–112. DOI:https://doi.org/10.22159/ijap.2022v14i5.44289.